Page last updated: 2024-08-26

mafosfamide and paclitaxel

mafosfamide has been researched along with paclitaxel in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Battaglia, M; Bertolini, F; Caprotti, M; Gibelli, N; Lanza, A; Palermo, B; Pavesi, L; Robustelli della Cuna, G	1
Huober, J; Mueck, AO; Seeger, H; Wallwiener, D	1

Other Studies

2 other study(ies) available for mafosfamide and paclitaxel

Article	Year
Multilineage long-term engraftment potential of drug-resistant hematopoietic progenitors. Blood, 1997, Oct-15, Volume: 90, Issue:8 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Blood Component Removal; Cells, Cultured; Cyclophosphamide; Drug Resistance; Fluorouracil; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-3; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; Paclitaxel; Phenotype; Receptors, Cell Surface; Stem Cell Factor; Transplantation Conditioning; X Chromosome	1997
Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations. European journal of gynaecological oncology, 2004, Volume: 25, Issue:6 Topics: 2-Methoxyestradiol; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Epirubicin; Estradiol; Female; Fluorouracil; Humans; Ovarian Neoplasms; Paclitaxel; Taxoids; Vinblastine; Vinorelbine	2004

Article

Year

Multilineage long-term engraftment potential of drug-resistant hematopoietic progenitors.

Blood, 1997, Oct-15, Volume: 90, Issue:8

Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Blood Component Removal; Cells, Cultured; Cyclophosphamide; Drug Resistance; Fluorouracil; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-3; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; Paclitaxel; Phenotype; Receptors, Cell Surface; Stem Cell Factor; Transplantation Conditioning; X Chromosome

1997

Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations.

European journal of gynaecological oncology, 2004, Volume: 25, Issue:6

Topics: 2-Methoxyestradiol; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Epirubicin; Estradiol; Female; Fluorouracil; Humans; Ovarian Neoplasms; Paclitaxel; Taxoids; Vinblastine; Vinorelbine

2004